Babylon stock price rose 20% amid acquisition rumors

Digital health company Babylon's stock price rose 20 percent Aug. 15 amid rumors of a coming acquisition.

The sharp rise in stock price led to the New York Stock Exchange stopping trading of Babylon common stock. Babylon has not had any discussions with a potential acquirer, according to the Aug. 15 Babylon news release.

By the end of the day Aug. 15, the stock had fallen 5 percent as the company attempted to shut down the speculation, according to The Motley Fool.

The acquisition rumors come after Babylon reported strong second-quarter earnings.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like